Clinical evaluation of Gokshuradi Guggulu and Pramehahara Guggulu in the management of Madhumehjanya updrava (Diabetic Nephropathy) An open label Randomized Comparative Clinical Trial

Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar0 个研究点目标入组 28 人开始时间: 待定最近更新: 2023年5月1日

试验速览

暂无简介。

•Both freshly detected and previously diagnosed cases of Diabetic nephropathy.
•Patients with a clinical positive history of only type 2 DM having clinical features of Diabetic nephropathy like albuminuria, raised serum creatinine and blood urea will be included.
•Patients with microalbumin >=30 and <= 299 mg/ 24 hour urine sample will be included.
•Patients diagnosed with First and second grade of Diabetic nephropathy will be included. Patients with s.creatine >=1.4 and <=5mg/dl.
•Patients with eGfr >=60 and <= 120ml/min/meter sq. will be included.

•Patient aged below 18 years and above 65 years, pregnant ladies.
•Patients with type 1 DM will be excluded.
•Patients with macroalbumin that is >=300 mg/24 hour urine sample will be excluded.
•Patients with an eGFR (glomerular filtration rate) less than 60 ml/min/1.73m2.
•Patients with serum creatinine level above 5 mg/dl.
•Female patients having pregnancy, lactating or post-delivery period.
•Patients suffering from HIV, TB other infectious diseases, malignancies, major psychiatric problems or any other serious illnesses.
•Patients with uncontrolled blood pressure will be excluded.

发起方

Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar